AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Influenza Vaccine
08/30/2016
The FDA has approved Afluria Quadrivalent for the use in individuals 18 years and older for active immunization against influenza cause by influenza A and B viruses.
08/30/2016
FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Influenza Vaccine
08/30/2016
The FDA has approved Afluria Quadrivalent for the use in individuals 18 years and older for active immunization against influenza cause by influenza A and B viruses.
08/30/2016
FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Influenza Vaccine
08/30/2016
The FDA has approved Afluria Quadrivalent for the use in individuals 18 years and older for active immunization against influenza cause by influenza A and B viruses.
08/30/2016
Infectious Diseases
Infectious Diseases
FDA: Screen All Blood Donations for Zika Virus
08/29/2016
The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.
08/29/2016
Infectious Diseases
Infectious Diseases
FDA: Screen All Blood Donations for Zika Virus
08/29/2016
The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.
08/29/2016
Infectious Diseases
Infectious Diseases
FDA: Screen All Blood Donations for Zika Virus
08/29/2016
The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.
08/29/2016
FDA
FDA
FDA Approves Injection for Treating Pediatric Lower Limb Spasticity
08/01/2016
The approval was based on results from a randomized, double-blind, prospective Phase 3 study of 235 pediatric patients.
08/01/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (lixisenatide)
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (lixisenatide)
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (lixisenatide)
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016